Cargando…
CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial
BACKGROUND: DAR-901 is an inactivated whole cell tuberculosis booster vaccine, prepared using a new scalable, broth-grown method from the master cell bank of SRL172, a vaccine previously shown to prevent tuberculosis. This study examined whether DAR-901 (a) induces CD4+ T cell cytokine profiles prev...
Autores principales: | Masonou, Tereza, Hokey, David A., Lahey, Timothy, Halliday, Alice, Berrocal-Almanza, Luis C., Wieland-Alter, Wendy F., Arbeit, Robert D., Lalvani, Ajit, von Reyn, C. Fordham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532882/ https://www.ncbi.nlm.nih.gov/pubmed/31120957 http://dx.doi.org/10.1371/journal.pone.0217091 |
Ejemplares similares
-
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901
por: von Reyn, C. Fordham, et al.
Publicado: (2017) -
Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis
por: Lahey, Timothy, et al.
Publicado: (2016) -
Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination
por: Lalvani, Ajit, et al.
Publicado: (2019) -
Polyantigenic Interferon-γ Responses Are Associated with Protection from TB among HIV-Infected Adults with Childhood BCG Immunization
por: Lahey, Timothy, et al.
Publicado: (2011) -
Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis
por: Halliday, Alice, et al.
Publicado: (2021)